First Time Loading...
C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 1.665 AUD -0.3% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

45.9m
-7%
Assets
Growth Rates:
1 Year
-7%
3 Years
+62%
5 Years
+95%
7 Years
+180%
10 Years
+410%
13.7m
-5%
Liabilities
Growth Rates:
1 Year
+5%
3 Years
+22%
5 Years
+109%
7 Years
+246%
10 Years
+155%
32.3m
-8%
Equity
Growth Rates:
1 Year
-12%
3 Years
+88%
5 Years
+90%
7 Years
+159%
10 Years
+781%

Balance Sheet Decomposition
Cyclopharm Ltd

45.9m
Assets
13.7m
Liabilities
45.9m
Assets
13.7m
Liabilities
Current Assets 30.2m
Cash & Short-Term Investments 11.7m
Receivables 7.9m
Other Current Assets 10.6m
Non-Current Assets 15.7m
PP&E 9.2m
Intangibles 5.7m
Other Non-Current Assets 796.1k
Current Liabilities 8.7m
Accounts Payable 6.9m
Other Current Liabilities 1.7m
Non-Current Liabilities 5m
Long-Term Debt 4m
Other Non-Current Liabilities 973k

Balance Sheet
Cyclopharm Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
3
6
5
9
6
13
2
29
20
12
Cash
0
0
0
0
0
13
2
29
20
12
Cash Equivalents
3
6
5
9
6
0
0
0
0
0
Total Receivables
3
4
4
5
6
4
9
8
8
8
Accounts Receivables
3
4
4
5
6
4
5
5
5
8
Other Receivables
0
0
0
0
0
1
4
3
2
0
Inventory
2
2
3
3
3
2
5
6
8
10
Other Current Assets
0
0
0
0
1
0
0
0
1
0
Total Current Assets
9
13
11
17
15
20
16
43
37
30
PP&E Net
1
1
2
3
2
6
6
6
7
9
PP&E Gross
0
0
0
0
0
6
6
6
7
0
Accumulated Depreciation
0
0
0
0
0
15
16
16
16
0
Intangible Assets
1
1
2
3
5
4
4
5
5
6
Goodwill
0
0
0
0
0
1
1
1
1
0
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
1
1
1
1
1
1
1
1
1
1
Other Assets
0
0
0
0
0
1
1
1
1
0
Total Assets
11
N/A
17
+51%
16
-1%
23
+42%
24
+1%
33
+38%
28
-13%
56
+97%
50
-11%
46
-7%
Liabilities
Accounts Payable
2
2
3
3
4
3
4
4
6
7
Accrued Liabilities
0
0
0
0
0
1
1
1
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
1
1
1
3
1
0
0
3
2
2
Total Current Liabilities
3
3
4
5
5
3
6
7
8
9
Long-Term Debt
0
0
0
0
0
5
5
4
4
4
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
1
1
1
1
1
1
1
Total Liabilities
3
N/A
3
+7%
4
+15%
6
+55%
7
+6%
9
+43%
11
+20%
13
+14%
13
+3%
14
+5%
Equity
Common Stock
15
15
15
22
22
32
32
63
63
64
Retained Earnings
7
2
2
4
4
8
14
19
26
31
Other Equity
1
0
1
1
1
1
1
1
1
1
Total Equity
8
N/A
13
+69%
12
-5%
17
+38%
17
-1%
23
+36%
17
-26%
43
+152%
37
-15%
32
-12%
Total Liabilities & Equity
11
N/A
17
+51%
16
-1%
23
+42%
24
+1%
33
+38%
28
-13%
56
+97%
50
-11%
46
-7%
Shares Outstanding
Common Shares Outstanding
58
60
60
68
69
78
80
93
93
94

See Also

Summary
CYC intrinsic value, competitors valuation, and company profile.
DCF Valuation
CYC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CYC stock valuation using valuation multiples.
Wall Street Estimates
CYC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CYC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.